Program Management Director/Senior Director
BridgeBio
Program Management Director/Senior Director
BridgeBio
Develops therapies for genetic diseases
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
The Director / Senior Director, Program Management, Portfolio Strategy & Management (PSM) runs the program review process that connects BridgeBio’s affiliate companies to executive decision-making. You will organize and plan the quarterly Program Review Meeting (PRM) cycle, help leadership and affiliates prepare, and track key deliverables and action items between meetings. You will also build and maintain the integrated timelines and milestone views behind the PRMs, and own the PSM Portal that gives leadership one trusted view of the portfolio. Senior Director scope includes broader program coverage, more complex cross-affiliate dependencies, and greater ownership of the PSM team’s structure and roadmap.
This role sits in the Office of the Chief Regulatory Officer (OCRO), and is part of the Portfolio Strategy & Management team. You will work daily with affiliate program teams, executive leadership and their chiefs of staff, IT, and the International organization.
Location: Hybrid, with 3 days a week in the SF/Palo Alto offices. Up to 10-20% travel may be required.
Director
Senior Director (in addition)
Both levels
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Financial Benefits
Health & Wellbeing
Skill Development & Career Paths
At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary: [$X - $Y USD, to be confirmed with Total Rewards]
As a global company, our comprehensive benefits may vary based on location. We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
For BridgeBio Full-Time U.S Based Roles:
Financial & Rewards
Health & Well-Being
Skill Development & Career Paths:
By applying, you acknowledge that BridgeBio will process your personal information as described in ourGlobal Candidate Privacy Notice.
Salary 255000 - 285000 USD
BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.
Explore more opportunities at BridgeBio